Treatment

Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
DMT use and clinical characteristics in MS by race and ethnicity 1:39
DMT use and clinical characteristics in MS by race and ethnicity
Carlos Pérez • 25 Feb 2021
Are COVID-19 vaccines safe and effective in the setting of MS DMTs? 4:06
Are COVID-19 vaccines safe and effective in the setting of MS DMTs?
Amit Bar-Or • 25 Feb 2021
Estrogen treatments to negate menopausal effects on disability severity in women with MS 6:12
Estrogen treatments to negate menopausal effects on disability severity in women with MS
Rhonda Voskuhl • 25 Feb 2021
Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
Changing approaches to cognitive assessment in MS 1:37
Changing approaches to cognitive assessment in MS
Tanuja Chitnis • 23 Feb 2021
Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis 1:45
Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis
Divyanshu Dubey • 15 Feb 2021
Clinical presentation and management of paraneoplastic neurological syndromes 2:24
Clinical presentation and management of paraneoplastic neurological syndromes
Divyanshu Dubey • 15 Feb 2021
Symptomatic extracranial vertebral artery stenosis: proximal stenting should be standard 3:29
Symptomatic extracranial vertebral artery stenosis: proximal stenting should be standard
Laszlo Csiba • 4 Nov 2020
Using ultrasound to classify plaques before treatment 2:55
Using ultrasound to classify plaques before treatment
Laszlo Csiba • 4 Nov 2020
Treating psychogenic seizures: CBT-IP 3:18
Treating psychogenic seizures: CBT-IP
W Curt LaFrance Jr • 5 Nov 2020
Treating psychogenic seizures in the US veteran population using video telehealth 2:41
Treating psychogenic seizures in the US veteran population using video telehealth
W Curt LaFrance Jr • 5 Nov 2020
A holistic approach to treating epilepsy and comorbidities 2:10
A holistic approach to treating epilepsy and comorbidities
W Curt LaFrance Jr • 5 Nov 2020
Revising the neuromyelitis optica criteria 4:39
Revising the neuromyelitis optica criteria
Angela Vincent • 30 Oct 2020
Comorbidities in multiple sclerosis patients 3:33
Comorbidities in multiple sclerosis patients
Melinda Magyari • 2 Nov 2020
Epilepsy treatment challenges: pregnancy planning and teratogenic potential 2:43
Epilepsy treatment challenges: pregnancy planning and teratogenic potential
Zeljka Petelin Gadže • 31 Oct 2020
The content of VJNeurology is intended for healthcare professionals